WO1995000618A1 - Contact lens solution containing peo and cationic cellulose - Google Patents

Contact lens solution containing peo and cationic cellulose Download PDF

Info

Publication number
WO1995000618A1
WO1995000618A1 PCT/US1994/006789 US9406789W WO9500618A1 WO 1995000618 A1 WO1995000618 A1 WO 1995000618A1 US 9406789 W US9406789 W US 9406789W WO 9500618 A1 WO9500618 A1 WO 9500618A1
Authority
WO
WIPO (PCT)
Prior art keywords
cellulosic polymer
composition
cationic
contact lens
groups
Prior art date
Application number
PCT/US1994/006789
Other languages
French (fr)
Inventor
Edward J. Ellis
Jeanne Y. Ellis
Original Assignee
Polymer Technology Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymer Technology Corporation filed Critical Polymer Technology Corporation
Priority to AU70615/94A priority Critical patent/AU7061594A/en
Publication of WO1995000618A1 publication Critical patent/WO1995000618A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/37Polymers
    • C11D3/3703Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C11D3/3707Polyethers, e.g. polyalkyleneoxides
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0078Compositions for cleaning contact lenses, spectacles or lenses
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/22Carbohydrates or derivatives thereof
    • C11D3/222Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
    • C11D3/227Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin with nitrogen-containing groups

Definitions

  • This invention relates to compositions for treating contact lenses, especially rigid, gas permeable contact lenses.
  • the surfaces of contact lenses must have a certain degree of hydrophilicity to be wet by tears. Tear wettability is in turn necessary to provide the lens wearer with comfort and good vision.
  • One way to impart wettability to contact lens surfaces is to add hydrophilic monomers to the mixture of comonomers used to form the contact lens material.
  • the relative amount of hydrophilic monomer added affects physical properties other than wettability.
  • the hydrophilic monomer content of rigid gas permeable lens materials is much less than that of soft, hydrogel lenses.
  • the rigid lenses accordingly contain only a few percent water of hydration whereas soft lenses contain amounts varying from 10 to 90 %.
  • hydrophilic monomer addition does increase wettability, the technique is limited by the influence that it has on other properties.
  • Another way to impart wettability to lens surfaces is to modify the surface after polymerization.. For example, surface coatings of hydrophilic polymers have been grafted onto the surface. Plasma treatment has also been used to increase the hydrophilicity of hydrophobic surfaces. Although effective, methods such as these are often expensive (requiring complicated and difficult manufacturing procedures) and impermanent.
  • United States Patent Nos. 4,168,112 and 4,321,261 disclose a method to overcome this drawback by immersing the lens in a solution of an oppositely charged ionic polymer to form a thin polyelectrolyte complex on the lens surface.
  • the complex increases the hydrophilic character of the surface for a greater period of time relative to an untreated surface.
  • cellulosic polymers bearing a cationic charge said polymers forming a strongly adhered hydrophilic layer on the contact lens surface. These polymers have proven to be exceptional components for wetting, soaking, and lubricating solutions.
  • PEO Polyethylene oxide
  • the invention provides aqueous compositions for treating contact lenses comprising a cationic cellulosic polymer and polyethylene oxide.
  • the compositions are especially effective at increasing the wettability of the surface of a lens treated therewith, particularly rigid, gas permeable (RGP) contact lenses. Additionally, the invention relates to methods of treating a contact lens which employ the compositions.
  • the invention provides aqueous compositions for treating contact lenses comprising a cationic cellulosic polymer and polyethylene oxide.
  • the cellulosic polymer component has a cationic charge, and the polymer should be compatible with the eye, non-irritating, and yet should form a hydrogel which is electrostatically bound to the surface of the contact lens treated with the composition.
  • Examples include cellulosic polymer containing N,N-dimethyl amino ethyl groups (either protonated or guaternized) , and cellulosic polymers containing N,N- dimethyl amino-2-hydroxylpropyl groups (either protonated or guaternized) .
  • Cationic cellulosic polymers are commercially available or can be prepared by methods known in the art.
  • the quaternary nitrogen-containing cellulosic polymers can be prepared by reacting hydroxyethyl cellulose with a trimethyl ammonium substituted epoxide.
  • Various preferred cationic cellulosic polymers are commercially available water soluble polymers available under the CTFA (Cosmetic, Toiletry, and Fragrance Association) designation Polyquaternium-10, including the cationic cellulosic polymers available under the tradename UCARE* Polymer from Amerchol Corp. , Edison, New Jersey, USA) . These polymers are believed to contain quaternized N,N- dimethyl amino groups along the cellulose polymer chain.
  • PEO Polyethylene oxide
  • PEG polyethylene glycol
  • the cationic cellulosic polymer absorbs rapidly and strongly on the surfaces of contact lenses, particularly lenses containing anionic sites, and once absorbed, this material desorbs very slowly.
  • PEO absorbs very weakly, at best, on such lens surfaces.
  • aqueous solutions of the cationic cellulosic polymers and PEO provide unique effects when used to treat a contact lens. More specifically, some type of complexation, or "entanglement", occurs between these two materials. Despite this complexation, the resultant complex is still able to absorb relatively strongly on the lens surface, thereby anchoring the PEO to the surface as well.
  • the compositions enhance the wetting ability, biocompatibility, and protein deposition resistance of contact lenses treated therewith.
  • the cationic cellulosic polymer may be employed at about 0.001 to about 10 weight percent of the composition, more preferably at about 0.01 to about 2 weight percent.
  • PEO may be employed at about 0.001 to about 10 weight percent of the composition, more preferably at about 0.01 to about 5 weight percent.
  • Typical contact lens solutions include necessary buffering agents for buffering or adjusting pH of the composition, and/or tonicity adjusting agents for adjusting the tonicity of the composition.
  • Representative buffering agents include: alkali metal salts such as potassium or sodium carbonates, acetates, borates, phosphates, citrates and hydroxides; and weak acids such as acetic, boric and phosphoric acids.
  • Representative tonicity adjusting agents include: sodium and potassium chloride, and those materials listed as buffering agents. The tonicity agents may be employed in an amount effective to adjust the osmotic value of the final composition to a desired value. Generally, the buffering agents and/or tonicity adjusting agents may be included up to about 10 weight percent.
  • an antimicrobial agent is included in the composition in an anti icrobially effective amount, i.e., an amount which is effective to at least inhibit growth of microorganisms in the composition.
  • the composition can be used to disinfect a contact lens treated therewith.
  • antimicrobial agents are known in the art as useful in contact lens solutions, including: chlorhexidine (1,l'-hexamethylene-bisfS-fp- chlorophenyl) biguanide]) or water soluble salts thereof, such as chlorhexidine gluconate; polyhexamethylene biguanide (PHMB, a polymer of hexamethylene biguanide, also referred to as polyaminopropyl biguanide) or water-soluble salts thereof, such as the polyhexamethylene biguanide hydrochloride available under the trade name Cosmocil CQ (ICI Americas Inc.); benzalkonium chloride; and polymeric quaternary ammonium salts.
  • the antimicrobial agent may be included at 0.00001 to about 5 weight percent, depending on the specific agent.
  • compositions may further include a sequestering agent (or chelating agent) which can be present up to about 2.0 weight percent.
  • sequestering agents include ethylenediaminetetraacetic acid (EDTA) and its salts, with the disodium salt (disodium edetate) being especially preferred.
  • compositions containing the cationic cellulosic polymer and PEO are ve y effective at providing the compositions with the ability to wet surfaces of contact lenses treated therewith.
  • the composition may include as necessary a supplemental wetting agent.
  • Representative wetting agents include: nonpolymeric cellulosic materials such as hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose and methylcellulose; polyvinyl alcohol; and polyvinyl pyrrolidone.
  • Such additives when present, may be used in a wide range of concentrations, generally about 0.1 to about 10 weight percent.
  • Contact lenses are treated with the compositions by contacting the lenses with the compositions.
  • a contact lens can be stored in the solution, or soaked in the solution, for sufficient time to wet the surfaces thereof.
  • the treated lens can be inserted directly in the eye, or alternately, the lens can be rinsed. Alternately, drops of solution can be placed on the lens surface and the treated lens inserted in the eye.
  • the specific lens care regimen used will depend on the other compounds present in the solution, as is well known in the art.
  • the a contact lens is preferably soaked in the composition for sufficient time to disinfect the lens and wet the surface thereof.
  • EXAMPLE 1 Solutions containing the following ingredients were prepared and passed through a 0.22 micron sterilizing filter in a clean room environment. The solutions were then packaged in sterile bottles.
  • UCARE* Polymer JR-30M is a polymeric quaternary ammonium salt of hydroxyethyl cellulose reacted with a trimethyl ammonium substituted epoxide, available from Amerchol Corp.
  • POLYOX WSR N-10 ® is a polymer of ethylene oxide wherein the number of ethylene oxide units averages 2000, supplied by Union Carbide Corp., Tarrytown, New York.
  • Solutions Al, Bl, Cl and Dl were evaluated on eye to assess clinical performance. Clean BOSTON RXD lenses for adapted RGP lens wearers were soaked in the solutions overnight. Each subject installed the lenses directly from the solution (no rinse step) and was examined immediately by a clinician who evaluated a number of parameters using a biomicroscope. The compiled results of the clinical evaluation of solutions Al through Dl are presented below.
  • the polymer complex (Bl and Cl) of the cationic cellulosic polymer and PEO provides an adsorbed layer on the contact lens surface which is compatible with the tear film and supports long tear break up time.
  • EXAMPLE 3 The solutions in Tables 3 and 4 were prepared as in Example 1, and dynamic contact angles (DCA) were determined on wafers of the RGP for the various solutions described in TABLE 1. The DCA results are summarized in TABLE 5.
  • the rates of adsorption were qualitatively determined by analyzing each of the seven individual dip cycles into the test solution. The rate of desorption was then determined by dipping a coated wafer into non-preserved phosphate buffer for 14 cycles. The measured advancing angle was utilized in both cases as a measure of absorbed polymer complex on the test material surface. In TABLE 5, the designation "mod.” denotes "moderate".

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Eyeglasses (AREA)

Abstract

Compositions for treating contact lenses comprise a cationic cellulosic polymer and polyethylene oxide.

Description

CONTACT LENS SOLUTION CONTAINING PEO AND CATIONIC
CELLULOSE
BACKGROUND OF THE INVENTION This invention relates to compositions for treating contact lenses, especially rigid, gas permeable contact lenses.
The surfaces of contact lenses must have a certain degree of hydrophilicity to be wet by tears. Tear wettability is in turn necessary to provide the lens wearer with comfort and good vision.
One way to impart wettability to contact lens surfaces is to add hydrophilic monomers to the mixture of comonomers used to form the contact lens material. However, the relative amount of hydrophilic monomer added affects physical properties other than wettability. For example, the hydrophilic monomer content of rigid gas permeable lens materials is much less than that of soft, hydrogel lenses. The rigid lenses accordingly contain only a few percent water of hydration whereas soft lenses contain amounts varying from 10 to 90 %. Thus, while hydrophilic monomer addition does increase wettability, the technique is limited by the influence that it has on other properties. Another way to impart wettability to lens surfaces is to modify the surface after polymerization.. For example, surface coatings of hydrophilic polymers have been grafted onto the surface. Plasma treatment has also been used to increase the hydrophilicity of hydrophobic surfaces. Although effective, methods such as these are often expensive (requiring complicated and difficult manufacturing procedures) and impermanent.
Water soluble polymers in lens care solutions have also been used to enhance the wettability of lens surfaces. Use of wetting polymers in this way provides a "cushion" between the lens and the eye which is . equated with increased wettability as wearer comfort and tolerance. However, a common drawback with this approach is that the cushion layer dissipates rapidly, since there is little specific interaction between the polymer and the lens surface.
United States Patent Nos. 4,168,112 and 4,321,261 disclose a method to overcome this drawback by immersing the lens in a solution of an oppositely charged ionic polymer to form a thin polyelectrolyte complex on the lens surface. The complex increases the hydrophilic character of the surface for a greater period of time relative to an untreated surface. Of particular interest are cellulosic polymers bearing a cationic charge, said polymers forming a strongly adhered hydrophilic layer on the contact lens surface. These polymers have proven to be exceptional components for wetting, soaking, and lubricating solutions.
While these cationic polymers are extremely effective for increasing the wettability of the lens, it would be desirable to enhance the biocompatibility of the complex formed by cationic cellulosic polymers to increase comfort to the eye.
Polyethylene oxide (PEO) is an unique water soluble polymer. When in an aqueous environment PEO does not perturb the structure of water and therefore is very "compatible" in a water matrix. Because of these unusual properties, PEO has been found to be an effective polymer for low protein adsorptions and low cell adhesion characteristics. However, PEO has little or no affinity for surfaces, frustrating attempts to employ PEO in solution as a biocompatibilizer. Rather, previous attempts to employ PEO as a biocompatibilizer have focused on coating PEO on polymeric surfaces, such as by grafting or covalently bonding PEO to the surfaces.
SUMMARY OF THE INVENTION The invention provides aqueous compositions for treating contact lenses comprising a cationic cellulosic polymer and polyethylene oxide. The compositions are especially effective at increasing the wettability of the surface of a lens treated therewith, particularly rigid, gas permeable (RGP) contact lenses. Additionally, the invention relates to methods of treating a contact lens which employ the compositions.
DETAILED DESCRIPTION OF THE INVENTION
The invention provides aqueous compositions for treating contact lenses comprising a cationic cellulosic polymer and polyethylene oxide.
The cellulosic polymer component has a cationic charge, and the polymer should be compatible with the eye, non-irritating, and yet should form a hydrogel which is electrostatically bound to the surface of the contact lens treated with the composition.
Examples include cellulosic polymer containing N,N-dimethyl amino ethyl groups (either protonated or guaternized) , and cellulosic polymers containing N,N- dimethyl amino-2-hydroxylpropyl groups (either protonated or guaternized) .
Cationic cellulosic polymers are commercially available or can be prepared by methods known in the art. As an example, the quaternary nitrogen-containing cellulosic polymers can be prepared by reacting hydroxyethyl cellulose with a trimethyl ammonium substituted epoxide. Various preferred cationic cellulosic polymers are commercially available water soluble polymers available under the CTFA (Cosmetic, Toiletry, and Fragrance Association) designation Polyquaternium-10, including the cationic cellulosic polymers available under the tradename UCARE* Polymer from Amerchol Corp. , Edison, New Jersey, USA) . These polymers are believed to contain quaternized N,N- dimethyl amino groups along the cellulose polymer chain.
Polyethylene oxide (PEO) , also called polyethylene glycol or PEG, improves the biocompatibility of the contact lenses treated with the solution, enhancing resistance to protein absorption of the lens. PEO is commercially available under a wide variety of tradenames from various suppliers.
The cationic cellulosic polymer absorbs rapidly and strongly on the surfaces of contact lenses, particularly lenses containing anionic sites, and once absorbed, this material desorbs very slowly. In contrast, PEO absorbs very weakly, at best, on such lens surfaces. Thus, although PEO enhances biocompatibility of polymeric surfaces, the use of PEO in solution to biocompatibilize such surfaces is not particularly effective.
Applicants have found that aqueous solutions of the cationic cellulosic polymers and PEO provide unique effects when used to treat a contact lens. More specifically, some type of complexation, or "entanglement", occurs between these two materials. Despite this complexation, the resultant complex is still able to absorb relatively strongly on the lens surface, thereby anchoring the PEO to the surface as well. The compositions enhance the wetting ability, biocompatibility, and protein deposition resistance of contact lenses treated therewith.
The cationic cellulosic polymer may be employed at about 0.001 to about 10 weight percent of the composition, more preferably at about 0.01 to about 2 weight percent. PEO may be employed at about 0.001 to about 10 weight percent of the composition, more preferably at about 0.01 to about 5 weight percent.
Typical contact lens solutions include necessary buffering agents for buffering or adjusting pH of the composition, and/or tonicity adjusting agents for adjusting the tonicity of the composition. Representative buffering agents include: alkali metal salts such as potassium or sodium carbonates, acetates, borates, phosphates, citrates and hydroxides; and weak acids such as acetic, boric and phosphoric acids. Representative tonicity adjusting agents include: sodium and potassium chloride, and those materials listed as buffering agents. The tonicity agents may be employed in an amount effective to adjust the osmotic value of the final composition to a desired value. Generally, the buffering agents and/or tonicity adjusting agents may be included up to about 10 weight percent.
According to preferred embodiments, an antimicrobial agent is included in the composition in an anti icrobially effective amount, i.e., an amount which is effective to at least inhibit growth of microorganisms in the composition. Preferably, the composition can be used to disinfect a contact lens treated therewith. Various antimicrobial agents are known in the art as useful in contact lens solutions, including: chlorhexidine (1,l'-hexamethylene-bisfS-fp- chlorophenyl) biguanide]) or water soluble salts thereof, such as chlorhexidine gluconate; polyhexamethylene biguanide (PHMB, a polymer of hexamethylene biguanide, also referred to as polyaminopropyl biguanide) or water-soluble salts thereof, such as the polyhexamethylene biguanide hydrochloride available under the trade name Cosmocil CQ (ICI Americas Inc.); benzalkonium chloride; and polymeric quaternary ammonium salts. When present, the antimicrobial agent may be included at 0.00001 to about 5 weight percent, depending on the specific agent.
The compositions may further include a sequestering agent (or chelating agent) which can be present up to about 2.0 weight percent. Examples of preferred sequestering agents include ethylenediaminetetraacetic acid (EDTA) and its salts, with the disodium salt (disodium edetate) being especially preferred.
The compositions containing the cationic cellulosic polymer and PEO are ve y effective at providing the compositions with the ability to wet surfaces of contact lenses treated therewith. If desired, the composition may include as necessary a supplemental wetting agent. Representative wetting agents include: nonpolymeric cellulosic materials such as hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose and methylcellulose; polyvinyl alcohol; and polyvinyl pyrrolidone. Such additives, when present, may be used in a wide range of concentrations, generally about 0.1 to about 10 weight percent.
Contact lenses are treated with the compositions by contacting the lenses with the compositions. For example, a contact lens can be stored in the solution, or soaked in the solution, for sufficient time to wet the surfaces thereof. The treated lens can be inserted directly in the eye, or alternately, the lens can be rinsed. Alternately, drops of solution can be placed on the lens surface and the treated lens inserted in the eye. The specific lens care regimen used will depend on the other compounds present in the solution, as is well known in the art. For compositions containing an antimicrobial agent, the a contact lens,,is preferably soaked in the composition for sufficient time to disinfect the lens and wet the surface thereof.
The following examples illustrate various preferred embodiments of the invention.
In the Examples, dynamic contact angle measurements were made on hydrated, polished wafers of a fluorosilicone rigid gas permeable (RGP) contact lens material (BOSTON RXD®, Polymer Technology Corporation, Boston, Massachusetts) utilizing a Cahn Instruments DCA 322. Wafers were dipped in the test solution 7 times at an average rate of 225 microns per second. All tests were run at room temperature. A computer assisted mathematical analysis of the data yields a graph of contact angle plotted against the vertical position on the wafer. The average advancing and receding contact angles were obtained from the graph.
EXAMPLE 1 Solutions containing the following ingredients were prepared and passed through a 0.22 micron sterilizing filter in a clean room environment. The solutions were then packaged in sterile bottles. In the Examples, UCARE* Polymer JR-30M is a polymeric quaternary ammonium salt of hydroxyethyl cellulose reacted with a trimethyl ammonium substituted epoxide, available from Amerchol Corp. POLYOX WSR N-10® is a polymer of ethylene oxide wherein the number of ethylene oxide units averages 2000, supplied by Union Carbide Corp., Tarrytown, New York.
Dynamic contact angles (DCA) were determined for the RGP material in various solutions described in TABLE 1. The DCA results are presented in TABLE 2. It is noted that Solution A lacked PEO and Solution D lacked a cationic cellulosic polymer. In Solution B, the ratio of cationic cellulosic polymer to PEO was 70:30, and in Solution C, this ratio was 30:70.
The dramatic lowering of the advancing contact angle with Solutions B and C indicates the presence of a polymer complex which is hydrophilic and bound to the surface.
TABLE 1
Solution
Figure imgf000013_0001
TABLE 2
Figure imgf000013_0002
Adv. Advancing contact angle in degrees
Rec Receding contact angle in degrees
Adv-Rec Difference between advancing and receding contact angles
EXAMPLE 2 Solutions designated Al, Bl, Cl and Dl were prepared as in Example 1. Each of Solutions Al, Bl, Cl and Dl corresponded to Solutions A, B, C and D, respectively, except that the solutions further included 15 ppm polyhexamethylene biguanide.
Solutions Al, Bl, Cl and Dl were evaluated on eye to assess clinical performance. Clean BOSTON RXD lenses for adapted RGP lens wearers were soaked in the solutions overnight. Each subject installed the lenses directly from the solution (no rinse step) and was examined immediately by a clinician who evaluated a number of parameters using a biomicroscope. The compiled results of the clinical evaluation of solutions Al through Dl are presented below.
TBUT* Wetting Tear Film
100% Surface Occasional Thin Spots 100% Surface Even over surface
Figure imgf000014_0001
100% Surface Occasional Thin Spots
Dl 3 100% Surface Occasional Thin Spots
*Tear Break-up Time (seconds)
The polymer complex (Bl and Cl) of the cationic cellulosic polymer and PEO provides an adsorbed layer on the contact lens surface which is compatible with the tear film and supports long tear break up time.
EXAMPLE 3 The solutions in Tables 3 and 4 were prepared as in Example 1, and dynamic contact angles (DCA) were determined on wafers of the RGP for the various solutions described in TABLE 1. The DCA results are summarized in TABLE 5.
Additionally, the rates of adsorption were qualitatively determined by analyzing each of the seven individual dip cycles into the test solution. The rate of desorption was then determined by dipping a coated wafer into non-preserved phosphate buffer for 14 cycles. The measured advancing angle was utilized in both cases as a measure of absorbed polymer complex on the test material surface. In TABLE 5, the designation "mod." denotes "moderate".
TABLE 3
Figure imgf000015_0001
TABLE 4
Solution
Figure imgf000016_0001
TABLE 5
Figure imgf000016_0002
Adv. (Abs) Advancing contact angle in degrees for absorption Adv. (Des) Advancing contact angle in degrees for desorption

Claims

We claim:
1. An aqueous solution for treating contact lenses comprises a cationic cellulose polymer and polyethylene oxide.
2. The composition of claim 1, wherein the cationic cellulosic polymer is selected from the group consisting of a cellulosic polymer containing N,N- dimethyl amino ethyl groups and a cellulosic polymer containing N,N-dimethyl amino-2-hydroxylpropyl groups.
3. The composition of claim 1, wherein the cationic cellulosic polymer is a cellulosic polymer containing guaternized N,N-dimethyl amino groups along the cellulose polymer chain.
4. The composition of claim 1 further comprising an antimicrobial agent.
5. The composition of claim 1 further comprising a wetting agent.
6. The composition of claim 1 further comprising a buffering agent.
7. The composition of claim 1 further comprising _a. onicity adjusting agent.
8. A method of treating a contact lens comprising contacting said contact lens with an aqueous composition which comprises a cationic cellulose polymer and polyethylene oxide.
9. The method of claim 8, wherein the cationic cellulosic polymer is selected from the group consisting of a cellulosic polymer containing N,N- di ethyl amino ethyl, groups and a cellulosic polymer containing N,N-dimethyl amino-2-hydroxylpropyl groups.
10. The method of claim 8, wherein the cationic cellulosic polymer is a cellulosic polymer containing guaternized N,N-dimethyl amino groups along the cellulose polymer chain.
11. The method of claim 8, wherein the composition further comprises at least one member selected from the group consisting of buffering agents and tonicity adjusting agents.
12. A method of disinfecting and wetting a contact lens comprising contacting said contact lens with an aqueous composition which comprises a cationic cellulosic polymer, PEO, and an antimicrobially effective amount of an antimicrobial agent.
13. The method of claim 12, wherein the cationic cellulosic polymer is selected from the group consisting of a cellulosic polymer containing N,N- di ethyl amino ethyl groups and a cellulosic polymer containing N,N-dimethyl amino-2-hydroxylpropyl groups.
14. The method of claim 12, wherein the cationic cellulosic polymer is a cellulosic polymer containing guaternized N,N-dimethyl amino groups along the cellulose polymer chain.
15. The method of claim 12, wherein the composition further comprises at least one member selected from the group consisting of buffering agents and tonicity adjusting agents.
PCT/US1994/006789 1993-06-18 1994-06-15 Contact lens solution containing peo and cationic cellulose WO1995000618A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU70615/94A AU7061594A (en) 1993-06-18 1994-06-15 Contact lens solution containing peo and cationic cellulose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8037293A 1993-06-18 1993-06-18
US08/080,372 1993-06-18

Publications (1)

Publication Number Publication Date
WO1995000618A1 true WO1995000618A1 (en) 1995-01-05

Family

ID=22156965

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/006789 WO1995000618A1 (en) 1993-06-18 1994-06-15 Contact lens solution containing peo and cationic cellulose

Country Status (2)

Country Link
AU (1) AU7061594A (en)
WO (1) WO1995000618A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997043373A1 (en) * 1996-05-13 1997-11-20 Bausch & Lomb Incorporated Composition and method for inhibiting the deposition of protein on contact lens
WO1999035520A1 (en) * 1998-01-09 1999-07-15 Novartis Ag Coating of polymers
US5948401A (en) * 1995-12-22 1999-09-07 Union Carbide Chemicals & Plastics Technology Corporation Cationic therapeutic systems
US6096138A (en) * 1997-04-30 2000-08-01 Bausch & Lomb Incorporated Method for inhibiting the deposition of protein on contact lens
WO2001082984A2 (en) * 2000-05-02 2001-11-08 Bausch & Lomb Incorporated Low ionic strength ophthalmic compositions
WO2002034308A2 (en) * 2000-10-24 2002-05-02 Bausch & Lomb Incorporated Prevention of bacterial attachment to biomaterials by cationic polysaccharides
WO2002047736A2 (en) * 2000-12-15 2002-06-20 Bausch & Lomb Incorporated Prevention of preservative uptake into biomaterials
US6451871B1 (en) 1998-11-25 2002-09-17 Novartis Ag Methods of modifying surface characteristics
US6719929B2 (en) 2000-02-04 2004-04-13 Novartis Ag Method for modifying a surface
US6793973B2 (en) 2000-02-04 2004-09-21 Novartis Ag Single-dip process for achieving a layer-by-layer-like coating
US6827966B2 (en) 2001-05-30 2004-12-07 Novartis Ag Diffusion-controllable coatings on medical device
US6852353B2 (en) 2000-08-24 2005-02-08 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US6858248B2 (en) 2001-05-30 2005-02-22 Novartis Ag Method for applying a coating to a medical device
US6893685B2 (en) 2000-08-24 2005-05-17 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US6896926B2 (en) 2002-09-11 2005-05-24 Novartis Ag Method for applying an LbL coating onto a medical device
US6926965B2 (en) 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8044112B2 (en) 2006-03-30 2011-10-25 Novartis Ag Method for applying a coating onto a silicone hydrogel lens
US8158192B2 (en) 2006-12-21 2012-04-17 Novartis Ag Process for the coating of biomedical articles
US8460743B2 (en) 2008-03-18 2013-06-11 Novartis Ag Coating process for ophthalmic lenses
US8689971B2 (en) 2007-08-31 2014-04-08 Novartis Ag Contact lens packaging solutions
US9005700B2 (en) 2011-10-12 2015-04-14 Novartis Ag Method for making UV-absorbing ophthalmic lenses
US9052442B2 (en) 2006-10-30 2015-06-09 Novartis Ag Method for applying a coating onto a silicone hydrogel lens
US9348061B2 (en) 2007-08-31 2016-05-24 Novartis Ag Contact lens products
US9829723B2 (en) 2015-12-03 2017-11-28 Novartis Ag Contact lens packaging solutions
US10338408B2 (en) 2012-12-17 2019-07-02 Novartis Ag Method for making improved UV-absorbing ophthalmic lenses

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401327A (en) * 1993-06-18 1995-03-28 Wilmington Partners L.P. Method of treating contact lenses

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1340516A (en) * 1969-12-01 1973-12-12 Burton Parsons Chemicals Inc Ophthalmic solution
US4168112A (en) * 1978-01-05 1979-09-18 Polymer Technology Corporation Contact lens with a hydrophilic, polyelectrolyte complex coating and method for forming same
US4436730A (en) * 1979-06-25 1984-03-13 Polymer Technology Corporation Ionic opthalmic cellulose polymer solutions
JPS6450014A (en) * 1987-08-20 1989-02-27 Tome Sangyo Kk Solution for contact lens
JPH01158412A (en) * 1986-12-26 1989-06-21 Daicel Chem Ind Ltd Cleaning and preserving liquid for contact lens

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1340516A (en) * 1969-12-01 1973-12-12 Burton Parsons Chemicals Inc Ophthalmic solution
US4168112A (en) * 1978-01-05 1979-09-18 Polymer Technology Corporation Contact lens with a hydrophilic, polyelectrolyte complex coating and method for forming same
US4321261A (en) * 1978-01-05 1982-03-23 Polymer Technology Corporation Ionic ophthalmic solutions
US4436730A (en) * 1979-06-25 1984-03-13 Polymer Technology Corporation Ionic opthalmic cellulose polymer solutions
JPH01158412A (en) * 1986-12-26 1989-06-21 Daicel Chem Ind Ltd Cleaning and preserving liquid for contact lens
JPS6450014A (en) * 1987-08-20 1989-02-27 Tome Sangyo Kk Solution for contact lens

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 8914, Derwent World Patents Index; Class A96, AN 89-103364 *
PATENT ABSTRACTS OF JAPAN vol. 013, no. 426 (P - 935) 22 September 1989 (1989-09-22) *

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948401A (en) * 1995-12-22 1999-09-07 Union Carbide Chemicals & Plastics Technology Corporation Cationic therapeutic systems
US6323165B1 (en) 1996-05-13 2001-11-27 Bausch & Lomb Incorporated Composition and method for inhibiting of protein on contact lens
WO1997043373A1 (en) * 1996-05-13 1997-11-20 Bausch & Lomb Incorporated Composition and method for inhibiting the deposition of protein on contact lens
AU722038B2 (en) * 1996-05-13 2000-07-20 Bausch & Lomb Incorporated Composition and method for inhibiting the deposition of protein on contact lens
US6096138A (en) * 1997-04-30 2000-08-01 Bausch & Lomb Incorporated Method for inhibiting the deposition of protein on contact lens
US7875660B2 (en) 1998-01-09 2011-01-25 Novartis Ag Biomedical devices having improved surface characteristics
AU745472B2 (en) * 1998-01-09 2002-03-21 Novartis Ag Coating of polymers
WO1999035520A1 (en) * 1998-01-09 1999-07-15 Novartis Ag Coating of polymers
US7705067B2 (en) 1998-01-09 2010-04-27 Novartis Ag Biomedical device having improved surface characteristics
US7566746B2 (en) 1998-01-09 2009-07-28 Novartis Ag Biomedical devices having improved surface characteristics
US7297725B2 (en) 1998-01-09 2007-11-20 Novartis Ag Biomedical devices having improved surface characteristics
US6451871B1 (en) 1998-11-25 2002-09-17 Novartis Ag Methods of modifying surface characteristics
US6719929B2 (en) 2000-02-04 2004-04-13 Novartis Ag Method for modifying a surface
US6793973B2 (en) 2000-02-04 2004-09-21 Novartis Ag Single-dip process for achieving a layer-by-layer-like coating
US7022379B2 (en) 2000-02-04 2006-04-04 Novartis Ag Single-dip process for achieving a layer-by-layer-like coating
WO2001082984A2 (en) * 2000-05-02 2001-11-08 Bausch & Lomb Incorporated Low ionic strength ophthalmic compositions
WO2001082984A3 (en) * 2000-05-02 2002-07-04 Bausch & Lomb Low ionic strength ophthalmic compositions
AU2001255210B2 (en) * 2000-05-02 2005-08-18 Bausch & Lomb Incorporated Low ionic strength ophthalmic compositions
US6893685B2 (en) 2000-08-24 2005-05-17 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US7040756B2 (en) 2000-08-24 2006-05-09 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
US6852353B2 (en) 2000-08-24 2005-02-08 Novartis Ag Process for surface modifying substrates and modified substrates resulting therefrom
WO2002034308A2 (en) * 2000-10-24 2002-05-02 Bausch & Lomb Incorporated Prevention of bacterial attachment to biomaterials by cationic polysaccharides
WO2002034308A3 (en) * 2000-10-24 2002-08-15 Bausch & Lomb Prevention of bacterial attachment to biomaterials by cationic polysaccharides
CN1292806C (en) * 2000-10-24 2007-01-03 博士伦公司 Prevention of bacterial attachment to biomaterials by cationic polysaccharides
WO2002047736A2 (en) * 2000-12-15 2002-06-20 Bausch & Lomb Incorporated Prevention of preservative uptake into biomaterials
US6805836B2 (en) 2000-12-15 2004-10-19 Bausch & Lomb Incorporated Prevention of preservative uptake into biomaterials
WO2002047736A3 (en) * 2000-12-15 2002-08-29 Bausch & Lomb Prevention of preservative uptake into biomaterials
US6827966B2 (en) 2001-05-30 2004-12-07 Novartis Ag Diffusion-controllable coatings on medical device
US7666461B2 (en) 2001-05-30 2010-02-23 Novartis Ag Diffusion-controllable coatings on medical device
US6858248B2 (en) 2001-05-30 2005-02-22 Novartis Ag Method for applying a coating to a medical device
US6926965B2 (en) 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US7582327B2 (en) 2002-09-11 2009-09-01 Novartis Ag LbL-coated medical device and method for making the same
US6896926B2 (en) 2002-09-11 2005-05-24 Novartis Ag Method for applying an LbL coating onto a medical device
US8044112B2 (en) 2006-03-30 2011-10-25 Novartis Ag Method for applying a coating onto a silicone hydrogel lens
US9052442B2 (en) 2006-10-30 2015-06-09 Novartis Ag Method for applying a coating onto a silicone hydrogel lens
US8158192B2 (en) 2006-12-21 2012-04-17 Novartis Ag Process for the coating of biomedical articles
US8689971B2 (en) 2007-08-31 2014-04-08 Novartis Ag Contact lens packaging solutions
US9162784B2 (en) 2007-08-31 2015-10-20 Novartis Ag Contact lens packaging solutions
US9348061B2 (en) 2007-08-31 2016-05-24 Novartis Ag Contact lens products
US8460743B2 (en) 2008-03-18 2013-06-11 Novartis Ag Coating process for ophthalmic lenses
US9005700B2 (en) 2011-10-12 2015-04-14 Novartis Ag Method for making UV-absorbing ophthalmic lenses
US10338408B2 (en) 2012-12-17 2019-07-02 Novartis Ag Method for making improved UV-absorbing ophthalmic lenses
US9829723B2 (en) 2015-12-03 2017-11-28 Novartis Ag Contact lens packaging solutions

Also Published As

Publication number Publication date
AU7061594A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
WO1995000618A1 (en) Contact lens solution containing peo and cationic cellulose
EP0703966B1 (en) Composition for wetting contact lenses
US5405878A (en) Contact lens solution containing cationic glycoside
US6096138A (en) Method for inhibiting the deposition of protein on contact lens
Bohnert et al. Adsorption of proteins from artificial tear solutions to contact lens materials.
US4440662A (en) Cleaning composition for contact lenses
JP2006509532A (en) Reduction of bacterial attachment to biomaterials and biomedical devices
JPH0520109B2 (en)
WO1990002555A1 (en) Aqueous antimicrobial ophthalmic solutions
KR20040007424A (en) Prevention of Preservative Uptake into Biomaterials
WO1994015649A1 (en) Preservative system for contact lens solutions
JP2006501301A (en) Compositions with enhanced antimicrobial efficacy against acanthamoebae
KR100420850B1 (en) Composition and method for inhibiting the deposition of protein on contactlens
US5451237A (en) Compositions and methods for inhibiting and reducing lysozyme deposition on hydrophilic contact lenses using biocompatible colored compounds
EP1278818B1 (en) Use of low ionic strength ophthalmic compositions
TW200413520A (en) Compositions and methods for inhibiting protein on surfaces
JP2788493B2 (en) Antimicrobial ophthalmic solution containing dodecyl-dimethyl- (2-phenoxyethyl) -ammonium bromide
JP2747354B2 (en) Solution for contact lens and method for hydrophilizing contact lens using the same
JPH09159975A (en) Aqueous solution for contact lens
JPH0641581A (en) Hydrophilic detergent for contact lens

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR BY CA CN CZ FI HU JP KP KR KZ LK LV MG MN MW NO NZ PL RO RU SD SK UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA